Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novel compounds versus Stelara in a humanized mouse model of psoriasis
NL-OMON35972Active, not recruiting
- Sponsor
- TNO
- Start
- Jun 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label trial of ustekinumab in psoriasis and plaque psoriasis, sponsored by TNO. Primary endpoints: Epidermal thickness and Histologic and immunohistochemical effect on psoriatic process. Started Jun 2011; status: active, not recruiting.
02
Drugs
ustekinumab
03
Conditions
psoriasisplaque psoriasis
Beyond the preview
Go deeper on NL-OMON35972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35972.